Vigabatrin 500 MG Oral Tablet [Sabril]

Known as: Sabril 500 MG Oral Tablet, VIGABATRIN 500 mg ORAL TABLET, FILM COATED [SABRIL] 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Vigabatrin (Sabril®), approved in the US in 2009, is currently indicated as adjunctive therapy for refractory complex partial… (More)
Is this relevant?
2016
2016
Vigabatrin (Sabril®) is an antiepileptic drug (AED) currently indicated in the US as a monotherapy for patients 1month to 2years… (More)
Is this relevant?
1997
1997
A case of a patient with medically intractable epilepsy, who developed obstructive sleep apnoea (OSA), and an increase in seizure… (More)
Is this relevant?
1997
1997
Vigabatrin (VGB) has been shown through several studies to be safe and effective as add-on therapy, particularly for the… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?